ID: ALA175345

Max Phase: Preclinical

Molecular Formula: C12H24N2O

Molecular Weight: 212.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)CCCCCN1CCN(C)CC1

Standard InChI:  InChI=1S/C12H24N2O/c1-12(15)6-4-3-5-7-14-10-8-13(2)9-11-14/h3-11H2,1-2H3

Standard InChI Key:  CUSFGABWVOUEBJ-UHFFFAOYSA-N

Associated Targets(Human)

Polyamine oxidase 84 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 212.34Molecular Weight (Monoisotopic): 212.1889AlogP: 1.38#Rotatable Bonds: 6
Polar Surface Area: 23.55Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.93CX LogP: 1.26CX LogD: 0.62
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.62Np Likeness Score: -0.59

References

1. Dredar SA, Blankenship JW, Marchant PE, Manneh V, Fries DS..  (1989)  Design and synthesis of inhibitors of N8-acetylspermidine deacetylase.,  32  (5): [PMID:2709384] [10.1021/jm00125a010]

Source